A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

Lucy Vivash, Charles B. Malpas, Leonid Churilov, Mark Walterfang, Amy Brodtmann, Olivier Piguet, Rebekah M. Ahmed, Ashley I. Bush, Christopher M. Hovens, T. Kalincik, David Darby, Dennis Velakoulis, Terence J. O'Brien

Research output: Contribution to journal › Article › Other › peer-review

5 Citations (Scopus)

1 results

Active

Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)
O'Brien, T., Malpas, C., Velakoulis, D., Piguet, O., Kalincik, T., Walterfang, M., Ahmed, R., Bush, A. I., Darby, D. G. & Brodtmann, A.
Department of Health and Aged Care (Australia)
1/04/19 → 31/03/25
Project: Research